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Summary 
lntegrin expression is normally confined to the basal 
layer of the epidermis, but when epidermal homeosta- 
sis is perturbed, the receptors are also expressed by 
suprabasal, differentiating keratinocytes. We have 
used the involucrin promoter to express functional hu- 
man integrin subunits a2, a5, and f3, in the suprabasal 
epidermal layers of transgenic mice. In mice express- 
ing cc5 or f3, alone or a& or a& heterodimers, there 
were hair and whisker abnormalities and a failure of 
eyelid fusion. In addition, mice expressing PI alone or 
in combination with a2 or a5 exhibited epidermal hyper- 
proliferation, perturbed keratinocyte differentiation, 
and skin inflammation, all of which are features of a 
common human skin disease, psoriasis. 
Introduction 
Epidermal keratinocytes express several extracellular ma- 
trix receptors of the integrin family, including three that 
share a common j3 subunit: a&, a collagen receptor; a&, 
a receptor for laminin; and a&, the keratinocyte fibronec- 
tin receptor (reviewed by Watt and Hertle, 1994). a& and 
a$, are abundantly expressed in normal epidermis, 
whereas expression of a& is up-regulated during wound 
healing, in psoriasis, and when keratinocytes are placed 
in culture. Experiments with cultured keratinocytes have 
established that f3, integrins not only mediate cell adhesion 
and migration, but also regulatestratification and the initia- 
tion of terminal differentiation (reviewed by Watt and Her- 
tle, 1994), and are markers that distinguish stem cells from 
keratinocytes of lower proliferative potential (Jones and 
Watt, 1993). 
Complex transcriptional and posttranslational regula- 
tory mechanisms ensure that integrin expression in the 
epidermis is normally confined to the basal layer of kera- 
tinocytes (Hotchin et al., 1993, 1995). However, there are 
a number of situations in which suprabasal, differentiating 
keratinocytes express integrins: e.g., during wound heal- 
ing and in psoriatic lesions (Hertle et al., 1992; reviewed 
by Watt and Hertle, 1994). Suprabasal integrin expression 
is not a direct consequence of inflammation since it is not 
induced by intradermal injections of cytokines that trigger 
an inflammatory response (Hertle et al., 1995). Rather, 
suprabasal expression is correlated with keratinocyte hy- 
perproliferation, abnormal terminal differentiation, or both. 
To investigate whether suprabasal integrin expression 
is a cause or a consequence of abnormal epidermal 
homeostasis, we used the human involucrin promoter 
(Carroll et al., 1993) to target integrin expression to the 
suprabasal layers of transgenic mouse epidermis. The 
transgenes encoded the human a2, a5, and j3, integrin sub- 
units, which could be distinguished from the endogenous 
mouse integrins by use of species-specific antibodies. 
Crossing of founder lines resulted in production of mice 
expressing human a& or a& suprabasally. Mice ex- 
pressing the f3, subunit have a phenotype that resembles 
psoriasis, a hyperproliferative inflammatory skin disorder 
that affects about 2% of the world’s population; these mice 
may therefore increase our understanding of the disease. 
Results 
Generation of Transgenic Mice 
Founder lines of transgenic mice were generated with the 
human a2, a5, and f3, integrin subunit cDNAs cloned into 
an involucrin expression cassette (containing the human 
involucrin promoter and intron; see Figure 1) described 
previously (Carroll et al., 1993). Potential founder animals 
were screened by polymerase chain reaction (PCR), and 
positive animals were outbred to Fl animals to establish 
founder lines. Three independent lines were established 
for each construct. The copy number, as determined by 
Southern blotting, varied widely among founder lines (Fig- 
ure 1). The phenotypes described for a given transgene 
were seen in all the founders, although the degree of se- 
verity and penetrance varied, being greatest in the lines 
expressing the highest copy number. 
To obtain mice expressing a& or a& heterodimers, 
we mated animals from the up and a5 lines with j& mice and 
screened the progeny for the presence of both transgenes. 
Since the lines used for the crosses were heterozygous, 
individual litters contained animals positive for one or both 
transgenes, together with negative littermates that served 
as controls. 
Expression of Transgenic and Endogenous 
lntegrin Subunits 
Reverse transcription (RT)-PCR established that each 
founder line was expressing the appropriate human inte- 
grin subunit in the skin, but not in liver or heart (data not 
shown). The sites of expression within the skin were deter- 
mined by in situ hybridization: the transgenes were ex- 
pressed in the suprabasal layers of the epidermis (Figure 
2a) and also within the inner root sheath of the hair follicles, 
where the involucrin promoter has previously been shown 
to be active (Carroll et al., 1993). Endogenous mouse invo- 
lucrin was present in the suprabasal layers of transgenic 
mouse epidermis, as judged by immunofluorescence (Fig- 
ure 2b), suggesting that the transgenic promoter was not 
interfering with the function of the mouse gene. No su- 
prabasal staining for laminin 1, type IV collagen, and fibro- 
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nectin (p, integrin ligands) was observed in transgenic epi- 
dermis, and the distribution of these extracellular matrix 
proteins in the basement membrane zone and dermis was 
indistinguishable in normal and transgenic mouse skin 
(data not shown). 
Antibodies specific for the human a2, as, or p, integrin 
subunits stained the suprabasal epidermal layers and in- 
0794 40 
0844 22 
0858 5 
1067 4.5 
1070 49 
1075 22 
ner root sheath in mice expressing the corresponding 
transgene and did not stain nontransgenic epidermis (Fig- 
ures 2c-2e; data not shown). The endogenous mouse inte- 
grin subunits we examined (an, a5, ag, and p,; Figures 2f 
and 2g; data not shown) were confined to the basal layer 
in normal mice. 
Since integrins are only expressed at the ceil surface 
Figure 2. lntegrin and lnvolucrin Expression 
Sections of cheek (a, g. and h) and back 
(b-f) skin. Panels are labeled to indicate type 
Of mouse (transgenic or control). (a) In situ hy- 
bridization. Arrowheads denote dermoepi- 
dermal junction. (b-h) lmmunofluorescence 
staining. 
(a) Human !3, probe, 0840 B, transgenic. 
(b) Mouse involucrin, 0840 8, transgenic. 
(c-e) Anti-human p, antibody (CD29). 
(c) Control, nontransgenic mouse. 
(d) 1067 x 0640 a&, transgenic. 
(e) 0840 p, transgenic. 
(9 Antibody detecting mouse 8, (Ha2/1 l), con- 
trol nontransgenic mouse. 
(g and h)Antibody detecting mouse as (GoH3). 
(g) Control, nontransgenic mouse. 
(h) 0840 PI transgenic. 
Scale bar, 60 pm. 
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as heterodimers (see, e.g., Hotchin et al., 1995), we did 
not expect to see cell surface human integrin in mice ex- 
pressing a single transgene. However, the staining pat- 
terns observed with anti-human f3, on epidermis from PI, 
a&, and a& mice were indistinguishable (compare Fig- 
ures 2d and 2e). Flow cytometry of isolated keratinocytes 
from f3, mice established that the human f3, subunit was 
expressed on the surface of differentiated cells at similar 
levels to the endogenous integrins on basal keratinocytes 
(data not shown). These observations led us to investigate 
whether the expression of endogenous integrin subunits 
was altered in mice expressing the PI transgene alone: 
immunofluorescence staining of mouse an, as, and f3, was 
unaffected (data not shown), but there was strong su- 
prabasal staining of a6 (compare Figures 2g and 2h). In 
contrast, a6 was not detected suprabasally in a& and a$, 
transgenic mice. Although as is normally expressed as a 
heterodimer with b4 in mouse and human keratinocytes 
(see, e.g., Tennenbaum et al., 1993), it is also capable of 
forming heterodimers with f3, (see Hertle et al., 1992). 
e 
The Transgenic lntegrins as Functional 
Extracellular Matrix Receptors 
To determine whether the transgenic integrins were func- 
tional, we cultured keratinocytes from a$, and a& mice 
and from control nontransgenic littermates. In low calcium 
medium, the keratinocytes grew as a monolayer, and in 
postconfluent cultures, terminally differentiating, involu- 
crin-positive cells rounded up and detached, as observed 
previously for human keratinocytes (Watt and Green, 
1982) (Figures 3a and 3b). There was no obvious differ- 
ence in the morphology of transgenic and nontransgenic 
cells, either when cultured in low calcium medium or in 
medium containing 1.2 mM calcium ions to allow stratifica- 
tion. The high plating density required in both media pre- 
cluded any assessment of growth rate. Many of the 
transgenic keratinocytes that were involucrin positive 
were also positively stained with an antibody to the human 
8, integrin subunit (Figures 3b and 3~). 
Keratinocytes from a&, a&, and nontransgenic mice 
were plated on type IV collagen (a ligand for a&) and 
no antibody +P502 +*A* 
10 antibody +P502 +SA2 
Figure 3. Cultured Keratinocytes 
(a-c) Low calcium culture of cells from a,p, 
mouse (1070 x 0840). Scale bar, 40 urn. 
(a) Phase contrast. 
(band c) Double-labeled immunofluorescence 
for involucrin (b) and human PI integrin sub- 
unit (c). 
(d-g) Adhesion assays. Transgenic cells in (d) 
were from the same founder lines as in (f) and 
(g). In (e)-(g), y axes are the percentage of ad- 
herent ceils that were involucrin positive. Note 
that the percentage of involucrin-positive cells 
in each starting population was approximately 
10%. Abbreviations: FN, IO uglml fibronectin; 
CIV, IO pglml type IV collagen; P5D2, inhibi- 
tory anti-human 8, antibody; 9A2, stimulatory 
anti-human 5, antibody. In (d), SEM is shown. 
See text for x2 analysis of data in (e)-(g). Data 
are pooled from duplicate (e-g) or triplicate(d) 
wells. 
(e) Nontransgenic cells. 
(9 a& cells (1070 x 0840). 
(g) a& cells (0794 x 0840). 
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Figure 4. Gross Phenotype of Control and 
Transgenic Mice 
(a-c) At 0.5 days after birth. The mouse shown 
in the top of (a) and in (c) is 0858 x 0869 asPI 
transgenic; that shown in the bottom of (a) and 
in (b) is a control littermate. (b) Eyelid is fused, 
no inflammation. (c) Eyelid has failed to fuse, 
and there is an inflammatory infiltrate in the 
exposed regions of the cornea (curved arrow) 
and eyelids. 
(d-f) At 3 months after birth. The mouse shown 
in the bottom of(d) and in (f) is 0794 x 0840 
a& transgenic; that shown in the top of(d) and 
in (e) is a control littermate. Hair follicles (back 
skin) areembedded in theadipose layer (brack- 
ets) in (9, but not in (e). Note in (9 that the 
hair follicles appear randomly oriented: arrows 
show one hair follicle in cross section (open 
arrow) and one in longitudinal section (solid 
arrow). 
(g and h) Shaved backs of 1070 x 0840 a$, 
transgenic (h) and control littermate (g), both 
animals aged 12 weeks. 
(b, c, e, and 9 Hematoxylin- and eosin-stained 
sections. 
fibronectin (the ligand for a&), and the number of adher- 
ent cells was measured as a percentage of the total num- 
ber of cells plated (Figure 3d; data not shown). There was 
no significant difference in the total number of adherent 
cells from each type of mouse (Figure 3d); however, this 
was not surprising, since the proportion of involucrin- 
positive cells (i.e., expressing the transgenes) in the cul- 
tures was only 10%-150/o. The experiments did allow us 
to establish that collagen and fibronectin concentrations 
of 10 kg/ml or greater supported maximal adhesion and 
showed that the transgenic integrins did not affect ligand 
binding by the endogenous integrins. 
When attachment of involucrin-positive cells was mea- 
sured, a difference between the a& transgenic and nor- 
mal mice was apparent: a greater proportion of involucrin- 
positive cells adhered to fibronectin in the transgenic than 
the nontransgenic cell populations (compare Figures 3e 
and 3g; p<O.OOOl). Since involucrin-negativecells adhere 
to extracellular matrix via the endogenous mouse inte- 
grins, the maximum percent adherent cells that could be 
involucrin positive will be about 10% (i.e., the proportion 
in the starting population). There was no significant differ- 
ence between control and a& involucrin-positive cells in 
adhesion to type IV collagen (Figures 3e and 3g). Adhesion 
of a& involucrin-positive cells tofibronectin could be mod- 
ulated with anti-human PI antibodies (P5D2 [inhibitory], 
p < 0.001; 8A2 [stimulatory], p = 0.083) while adhesion 
to type IV collagen could not (p > 0.281) (Figure 39). The 
proportion of a& involucrin-positive cells that adhered to 
collagen was lower than the proportion of a& involucrin- 
positive cells adhering to fibronectin (Figures 3f and 3g), 
and although a& involucrin-positive cells appeared to 
show selective adhesion to type IV collagen, the data are 
not statistically significant (Figure 3f). 
Transgenic Mice Have Abnormalities 
of Skin, Hair, and Eyelids 
Several abnormalities were evident from gross inspection 
of the transgenic mice that were never seen in non- 
transgenic control mice (Table 1; Figure 4). A significant 
proportion of the animals expressing a5, PI, a&,, or a& 
were born with open eyes, were runted, and had fewer 
whiskers than the nontransgenic littermates (Figure 4a). 
These phenotypes were most common in a& animals 
(Table 1). Histological sections of the eyes of newborn 
mice (Figures 4b and 4c) showed that there had been a 
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Table 1. Summary of Transgenic Phenotypes 
Phenotypes 
Transgenic Subunit(s) Open Eyes at Birth 
a2 0 of 46 
a5 7 of 64 
81 25 of 82 
a& 7 of 27 
ad% 17of23 
Whisker/Hair Abnormalities 
0 of 46 
4 of 64 
8 of 82 
6 of 27 
18of23 
Epidermal Hyperplasia 
Oof 14 
Oof 11 
14of22 
17 of 19 
8of 11 
inflammation 
Oof 14 
Oof 11 
9 of 22 
13 of 19 
4of 11 
Animals from the 1070 (az), 0794(a& and 0840 @,)founder lineswere examined. Data were pooled from multiple litters. Hyperplasiaand inflammation 
were assessed by examining hematoxylin- and eosin-stained sections of the skin of animals sacrificed 6-16 weeks after birth; mild, moderate, 
and severe phenotypes were all scored as positive. 
- 
failure of eyelid fusion prior to birth (see Findlater et al., 
1993) and that there was an inflammatory exudate in the 
cornea and eyelid. In adult mice, there were opaqueness 
of the eyeball and cornea1 scarring. 
Adult mice expressing the a5 or 5, transgenes also had 
abnormalities of the hairs of the coat and whiskers, the 
incidence being highest when the transgenes were coex- 
pressed (Table 1; Figures 4d-49. The hairs of the coat 
did not have the uniform orientation seen in control mice 
of the same hair cycle, and the whiskers were short and 
curly (Figure 4d). The coat phenotype was seen in all sites 
examined (skin of the upper, middle, and lower back and 
belly). Histological sections of the dorsal skin of mice with 
abnormal coat hair showed that the follicles were disorga- 
nized and abnormally orientated and extended deeper into 
the dermis than in control littermates (Figures 4e and 4f); 
the morphology of individual follicleswas also altered, with 
enlargement of the follicles themselves and of the associ- 
ated pilosebaceousglands. Individual hairsof affected ani- 
mals were wavy rather than straight (data not shown). The 
abnormal coat phenotype was apparent as soon as the 
first coat developed, and there was a progressive normal- 
ization through successive hair growth cycles. 
Mice expressing the 5, transgene, alone or in combina- 
tion with a2 or as, also showed gross evidence of epidermal 
abnormalities and immune involvement (Table 1; Figures 
4g and 4h). Flaking of the epidermis could readily be de- 
tected on the chin, behind the ears, and under the limbs or 
after shaving the hair from the back or belly of the animals 
(Figures 4g and 4h). In some mice, inflammation was seen 
as a reddening of the skin of chin and paws, and there 
were pustules on the surface of the dorsal skin (Figure 4h). 
Although some animals with hair abnormalities also had 
flaking and inflamed skin, others (see Figure 4f) did not. 
The flaking and inflammation of the skin were not ob- 
served in any animals before 6 weeks of age and went 
through cycles of spontaneous regression, making it diffi- 
cult to gauge the penetrance of the phenotype. Thus, the 
data shown in Table 1, which were obtained foltowing his- 
tological examination (see Figure 5), are almost certainly 
an underestimate of penetrance. When animals were 
housed separately to prevent damage to the skin from 
fighting, flaking and inflammation were still observed. 
Gram and periodic acid-Schiff reagent staining of sections 
of skin from affected animals revealed no sign of bacterial 
or fungal infection. 
Figure 5. Histology of Dorsal Skin 
Hematoxylin- and eosin-stained sections. 
(a) Control, nontransgenic. 
(b) 0840 6, transgenic. Note thickening of epidermis to right of field, 
with increased dermal cellularity underneath the thickened epidermis, 
(c) 0794 x 0869 a&, transgenic. Small arrows, suprabasal epidermal 
mitoses; large arrows, dilated capillaries. 
(d) 1067 x 0840 a&, transgenic. Curved arrow, pustule in parakera- 
totic cornified layers. 
Scale bar, 60 pm. 
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Figure 6. Proliferation and Keratin Expression 
Sack skin of control (a, d, and g) and 0846 6~ transgenic (b, c, e, f, h, and i) mice. Sections of transgenic skin were chosen to illustrate mild (b, 
e, and h) and severe (c, f, and i) phenotypes. Staining in (a)-(c) is Ki-87, in (d)-(f) is Kl, and in (g)-(i) is K6. Note that K6 staining in (h) is more 
SXtSnSiVS in the hyperplastic epidermis in the left of the micrograph than in the more normal epidermis in the right. scale bar, so pm, 
A group of 41 mice from eight different litters of the 0840 
5, founder line was observed three times a week for 12 
weeks. During that time, 22 of the animals developed flak- 
ing of the skin; animals were affected for l-2 weeks and 
then went into remission. The number of episodes per 
animal during the observation period ranged from one to 
three. Occasional animals (not included in the group of 
41) never went into remission. Affected animals within a 
given litter did not exhibit the phenotype synchronously. 
The incidence of flaking and inflammation was the same 
among males and females. 
Epidermal Proliferation and Terminal Differentiation 
The epidermis of adult mice expressing 5,, a&,, or a& 
was examined histologically for evidence of abnormal pro- 
liferation and differentiation (Figure 5). Histopathological 
features were similar in the skin from 5,, a&,, or a& mice. 
Abnormal histology was focal in the epidermis and under- 
lying dermis of mildly affected animals, but covered exten- 
sive areas of more severely affected mice. All biopsies 
were matched for age, sex, and body site, and transgene- 
negative littermates were compared whenever possible. 
Skin from all trunk sites showed abnormal histology, but 
skin from tail, ear tips, and cheek did not. Different trunk 
sites of a given animal could show varying severity of phe- 
notype, but there was no correlation between site (e.g., 
back versus belly) and severity. 
Figure 5 shows hematoxylin- and eosin-stained sections 
of skin from the back of a normal mouse (Figure 5a) and 
sections of transgenic mouse skin (Figures 5b-5d). Fig- 
ures 5b-5d have been chosen to show the variation in 
severity of epidermal hyperproliferation and inflammation. 
In mildly affected animals (Figure 5b), epidermal thick- 
ening was often observed adjacent to a relatively unaf- 
fected area; in the dermis directly below the thickened 
epidermis, an increased cellularity was apparent. In more 
severely affected animals (Figure 5c), there was wide- 
spread thickening (hyperplasia) of the epidermis, re- 
flecting both an increase in the number of viable cell layers 
(acanthosis) and cornified layers (hyperkeratosis). There 
were alternating regions of anucleate (orthokeratotic) and 
nucleated (parakeratotic) cornified cells, the underlying 
granular layer being absent in regions of parakeratosis. 
In the most severe phenotype, there were neutrophil- 
containing pustules within or beneath the cornified layers 
and large numbers of lymphocytes and polymorphs within 
the epidermis (Figure 5d). Dermal involvement was wide- 
spread in the intermediate and severely affected mice and 
was characterized by infiltration of lymphocytes and neu- 
trophils into the dermis, dermal mitoses, and dilated capil- 
laries (Figures 5c and 5d). Using the TdT-mediated dUTP- 
biotin nickend-labeling (TUNEL) technique, we found that 
there were no major differences in the number of keratino- 
cytes with apoptotic nuclei in normal or in mildly or severely 
affected epidermis (data not shown). 
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Figure 7. Immune Response 
Sections of back skin of control (a, d, g, and j), 0794 x 0669 a& transgenic (b, e, h, and k), and 1070 x 0640 a& transgenic (c, f, i, and I) mice, 
Sections of transgenic skin were chosen to illustrate mild (b, e, h, and k) and severe (c, f, i, and I) phenotypes, lmmunostaining for (a)-(c) is CD3, 
for (d)-(f) is CD4, for (g)-(i) is CD& and for (j)-(l) is ICAM-1. Epidermal fluorescence in (d), (g),and (j) was the same as in sections stained with 
second antibody alone. Scale bar, 60 urn. 
The histological appearance of skin from the j3,, a&, 
and a& mice suggested that keratinocyte proliferation 
was increased and that terminal differentiation was per- 
turbed. This was confirmed by immunostaining for Ki-67, 
a nuclear protein expressed by proliferating cells (Schltiter 
et al., 1993), and for the epidermal keratins Kl and K6 
(Heyden et al., 1994). 
Relatively few Ki-67-positive cells were seen in the dor- 
sal epidermis of nontransgenic mice, and all of the positive 
cells were in the basal layer (6.2% f 0.8% of basal cells 
were Ki-67 positive; Figure Sa). In mildly affected epider- 
mis of transgenic mice, the number of Kid7-positive cells 
in the basal layer was increased (32.6% f 4.6%; Figure 
6b), while in the most severely affected epidermis, the 
majority of basal (79% f 7.4%) and many suprabasal 
keratinocytes were Ki-67-positive (Figure 6~). Increased 
Ki-67 labeling was also noted in the hair follicles (compare 
Figures 6a-6c). 
In normal and mildly affected epidermis, Kl was ex- 
pressed by all keratinocytes that had left the basal layer 
(Figures 6d and se), but in severely affected epidermis, 
Kl expression was patchy (Figure 6f). In normal skin, K6 
was confined to the hair follicles (Figure 6g), but in the 
transgenic mice, K6 was expressed in hyperproliferative 
epidermis (Figures 6h and 6i). Figure 6h shows the bound- 
ary between areas of normal and mildly hyperproliferative 
epidermis, with strong K6 staining suprabasally in the af- 
fected region. Figure 6i shows a severely affected area, 
where K6 staining of all the epidermal layers is apparent. 
Characterization of the Inflammatory Infiltrate 
in the Skin of Transgenic Mice 
To investigate the nature of the inflammatory infiltrate in 
the affected mice, we labeled sections of dorsal skin with 
antibodies to the T lymphocyte markers CD3 (T cell recep- 
tor and pan-T cell marker), to CD4 and CD8, and to ICAM- 
(CD54), which is induced on the surface of keratinocytes 
by proinflammatory stimuli (see, e.g., Hertle et al., 1995). 
Control mouse skin contained resident dendritic CD3- 
positive cells in the epidermis and hair follicles (most prob- 
ably y6 T cells; see Asarnow et al., 1988), but no CD4- 
positive, CD8-positive, or ICAM-l-positive cells (Figures 
7a, 7d, 79, and 7j). 
In mildly hyperproliferative epidermis, the number of 
CDS-positive dendritic cells in the epidermis (but not in the 
hair follicles) was reduced (Figure 7b), while CD&positive 
lymphocytes were present in the epidermis (Figure 7h). 
CDCpositive cells were present in the epidermis and der- 
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mis (Figure 7e). intense focal staining for ICAM- was ob- 
served in all layers of the epidermis and in the underlying 
dermis (Figure 7k). 
In the most severely affected mice, there were many 
more CD&positive lymphocytes in the epidermis than 
found in mildly affected animals (compare Figures 7h and 
7i), and the number of CD4-positive cells in the dermis 
was also increased (compare Figures 7e and 7f). There 
were numerous CD3-positive cells in the epidermis and 
dermis (Figure 7~). ICAM- staining was less intense but 
more extensive in the severe lesions (Figure 71) than in 
mildly affected epidermis (Figure 7k). 
Discussion 
Strong evidence for a role of integrins in disease has come 
from the identification of integrin gene mutations in inher- 
iteddisorders(see, e.g., Wardlawetal., 1990)andfromthe 
efficacy of integrin antagonists in the treatment of some 
cancers and cardiovascular disease (see, e.g., Brooks et 
al., 1994). Nevertheless, there is a much wider range of 
conditions that are correlated with abnormal integrin 
expression or function, but for which a direct link with 
pathogenesis is lacking. We and others have noted that 
suprabasal integrin expression is commonly seen in situa- 
tions in which keratinocytes are hyperproliferative (re- 
viewed by Watt and Hertle, 1994); our transgenic model 
now demonstrates that this relationship is causal. 
The involucrin promoter is active in keratinocytes during 
eyelid and hair follicle development (J. M. C. and F. M. W., 
unpublished data), and the as, PI, and a& transgenic mice 
had defects in those structures (failure of eyelid fusion and 
disorganized follicles) that were strikingly similar to those 
of animals containing mutations or disruptions in the 
genes encoding transforming growth factor a (TGFa) 
(Luetteke et al., 1993; Mann et al., 1993) the epidermal 
growth factor (EGF) receptor (Luetteke et al., 1994), the 
activinlinhibin (38 subunit (Vassalli et al., 1994), or cab/ 
(Schwartzberg et al., 1991). The similarities between the 
integrin mice and mice with disrupted growth factor signal- 
ing pathways may be more than coincidental because 
growth factors are known to regulate integrin levels in kera- 
tinocytes (see, e.g., Zambruno et al., 1995). We therefore 
speculate that specific growth factors may be regulating 
the temporal and spatial patterns of integrin expression 
in keratinocytes during development and that perturbation 
of the growth factor signaling pathways or of integrin ex- 
pression will therefore result in similar developmental ab- 
normalities. Furthermore, the association of eyelid and 
hair follicle defects with misexpression of the a5 subunit, 
but not the a2 subunit, argues for specificity of integrin 
function in developing epithelia. 
Psoriasis is a common human skin disease that is char- 
acterized by increased keratinocyte proliferation, abnor- 
mal differentiation, and inflammation of the dermis and 
epidermis (Krueger et al., 1984). Adult transgenic mice 
expressing the 8, transgene, alone or in combination with 
a2 or a5, had many features reminiscent of adult chronic 
plaque psoriasis, specifically psoriasis vulgaris. In hu- 
mans and these transgenic mice, the early changes in- 
clude increased proliferation of basal keratinocytes, hy- 
perkeratosis (i.e., increased number of cornified cells), 
increased dermal mitoses and capillary dilation, and an 
influx of CD4-positive and CD8-positive T lymphocytes. 
More severe lesions are characterized by severe hyperpla- 
sia (thickening of the epidermis), regions of parakeratosis 
with loss of underlying granular cells, and large numbersof 
epidermal CD&positive cells and of dermal CDCpositive 
cells. In the mice, neutrophil-laden pustules similar to the 
Munro microabscesses of psoriasis vulgaris were com- 
monly observed. As in psoriasis, there was induction of 
ICAM- and an increase in Ki-67 labeling (see Paukkonen 
et al., 1995); K6 was induced in the interfollicular epider- 
mis, and the level of Kl was decreased (see Stoler et al., 
1988). The only major feature of psoriasis not reproduced 
in the mice was elongation of the rete ridges, but since 
the dermoepidermal junction in normal mice is flat (i.e., 
lacking rete ridges), this is not surprising. Other interesting 
parallels with the mice are the frequent lack of psoriasis 
development before adulthood, the waxing and waning of 
the disease, and the variation in phenotype with body site 
(Krueger and Duvic, 1994). Psoriasis is also believed to 
have genetic and environmental components (Krueger 
and Duvic, 1994), and we speculate that this could explain 
the degree of penetrance of the phenotype in our mice, 
which have a mixed genetic background. Other animal 
models (transgenic or spontaneous mutants) have some 
features of psoriasis, but none share as many characteris- 
tics of the disease as the integrin transgenics (see Leonard 
et al., 1988; Wilson et al., 1990; Hammer et al., 1990; 
Vassar and Fuchs, 1991; Dominey et al., 1993; Sundberg 
et al., 1993). 
In the transgenic mice expressing j3,, a&, or a&, there 
were keratinocyte hyperproliferation and abnormal termi- 
nal differentiation and an immune response in the skin. 
While the need to sacrifice animals for histology made it 
impossible to follow the evolution of individual lesions, 
Ki-67 labeling showed that there could be keratinocyte 
hyperproliferation in the absence of an inflammatory infil- 
trate (Figure 6b); in contrast, we never saw inflammation 
without keratinocyte hyperproliferation and abnormal dif- 
ferentiation. This strongly suggests that the primary cause 
of the psoriasiform phenotype in these mice is the effect 
of abnormal integrin expression on the keratinocytes. 
How does suprabasal integrin expression trigger hyper- 
proliferation? The mechanism may depend on the func- 
tional status of the receptors. 8, integrins in keratinocytes 
can exist in an active (high affinity for ligand) or inactive 
(low ligand binding affinity) state, the transition between 
the two states being reversible (Hotchin et al., 1993). Al- 
though the transgenic a& integrin bound to fibronectin 
in adhesion assays of cultured keratinocytes, we do not 
know the activation state of the transgenic receptors in 
vivo. They might be inactive, as a result of the absence 
of suprabasal type IV collagen and fibronectin ligands (see 
Hotchin et al., 1993), or they might have a nonmatrix bind- 
ing role, for example, in intercellular adhesion (see Sym- 
ington et al., 1993). 
lntegrins and Psoriasis 
965 
At present we can only speculate how suprabasal inte- 
grin expression causes such profound changes in the epi- 
dermis. Unoccupied integrins can trigger apoptotic cell 
death (Ruoslahti and Reed, 1994), but we did not observe 
asignificant increase in apoptosis in transgenic epidermis. 
Since the earliest change is in the basal layer of the epider- 
mis, where the transgenes are not expressed, we favor a 
model in which the presence of the integrins in the differ- 
entiating cell layers stimulates proliferation in the basal 
layer, perhaps by signaling that there is a deficit in the 
size of the differentiated compartment that should be re- 
plenished through increased proliferation. The abnormali- 
ties in the terminal differentiation compartment, such as 
induction of K6, are probably a consequence of the hyper- 
proliferative state of the epidermis. Additional factors, 
such as the hair growth cycle, could affect the onset of 
hyperplasia. 
One surprising finding was that mice expressing 8, 
alone had the same phenotype as mice expressing a& 
or a&. In the PI-only mice, the endogenous a6 subunit 
was present suprabasally, but not in the a& or a& mice. 
It is not known how the transgene is affecting endogenous 
integrin expression nor why the effect is specific for mouse 
a6 and not a2 or a5. However, it is interesting that during 
human epidermal wound healing, a6 is also expressed 
suprabasally in the absence of the p4 subunit (Hertle et 
al., 1992), and further studies are necessary to determine 
what the function of a& is in keratinocytes and whether 
the up-regulation of a6 is via transcriptional or posttransla- 
tional mechanisms (see Hotchin et al., 1995). 
There are two potential causes for the immune response 
in the skin of the transgenic animals: it could be triggered 
by specific antigens or by the release of inflammatory me- 
diators. It is most unlikely that the mice are mounting an 
immune response to the human integrins themselves, be- 
cause the involucrin promoter is first expressed at embry- 
onic day 9.5 (E9.5), before the thymus develops (J. M. C. 
and F. M. W., unpublished data), and because inflamma- 
tion was not seen until 6 weeks after birth. Furthermore, 
keratinocytes are not professional antigen-presenting 
cells, and constitutive expression of the costimulatory mol- 
ecule 67 (Williams et al., 1994; Nasir et al., 1994) or of 
ICAM- (Williams and Kupper, 1994) in the epidermis of 
transgenic mice does not result in spontaneous cutaneous 
inflammation. Since the integrin transgenic mice were free 
of bacterial and fungal infection, a role of classical super- 
antigens is also unlikely (see Valdimarsson et al., 1995). 
We believe it to be more likely that, as a consequence of 
integrin-induced aberrant proliferation and differentiation, 
keratinocytes are releasing cytokines and chemokines 
that in turn trigger an inflammatory reaction. Psoriatic epi- 
dermis is characterized by production of a complex mix- 
ture of multiple cytokines and chemokines (reviewed by 
Krueger and Gottlieb, 1994), and so it is not surprising 
that targeted expression of individual cytokines in the epi- 
dermis of transgenic mice does not recreate the pheno- 
type, even though there are dramatic effects on epidermal 
proliferation and differentiation (see, e.g., Vassar and Fuchs, 
1991; Cheng et al., 1992; Turksen et al., 1992; Dominey 
et al., 1993; Guo et al., 1993). Further experiments are 
now required to characterize the immune response and 
cytokinelchemokine profile of the integrin transgenics, 
and it will be interesting to test known immunosuppressive 
antipsoriatic regimens, such as cyclosporin, on the mice. 
There is a long-standing debate about whether psoriasis 
is primarily a disorder of the immune system or of keratino- 
cytes (see, e.g., Gottlieb et al., 1995); the data from the 
integrin transgenic mice strongly support the view that 
the defect is in the keratinocytes. The mice offer novel 
approaches to understanding the causes and mecha- 
nisms of the disease and suggest a whole new range of 
potential drugs, integrin antagonists, as potential antipso- 
riatic compounds. Suprabasal integrin expression is now 
clearly established as a cause of abnormal keratinocyte 
behavior, and we are at present investigating its signifi- 
cance in other diseases such as squamous cell carcinoma 
(Tennenbaum et al., 1993). 
Experimental Procedures 
Transgene Construction 
lntegrin cDNAs were cloned into the Not1 site of an involucrin expres- 
sion cassette consisting of 2.5 kb of the human involucrin upstream 
region, the involucrin intron, an SV40 intron, and an SV40 polyadenyla- 
tion sequence (Figure 1; Carroll et al., 1993). The cDNA for human 
czz integrin was excised from the plasmid pJ7(provided by F. Berdishev- 
sky and J. Taylor-Papadimitriou, Imperial Cancer Research Fund) as 
an Xbal-Kpnl fragment, blunt ended, and ligated to Not1 linkers. The 
human a5 cDNA was excised from the pECE plasmid as a Sall-Xbal 
fragment, blunt ended, and ligated to Notl linkers, and the human p, 
cDNA was excised from pECE as an EcoRl fragment, blunt ended, 
and ligated to Notl linkers (a, and 8, plasmids were provided by E. 
Ruoslahti, La Jolla Cancer Research Center: Giancotti and Ruoslahti, 
1990). All transgenes were excised from the parent plasmids as Sall 
fragments, purified as described previously (Carroll et al., 1993), and 
resuspended in sterile PBS at a concentration of 5 pglml for oocyte 
injection. 
Preparation of Transgenic Mice and Determination of Transgene 
Tissue Specificity and Copy Number 
DNA constructs were injected into fertilized oocytes from (CBA x 
C57BUlO)Fl mice. Founders were backcrossed to establish lines of 
animals, and Fl or later generation progeny were analyzed. Animals 
were kept on an established 12 hr:12 hr light:dark cycle in an SPF 
facility. 
Animals were screened for the presence of transgenes using PCR 
of ear DNAwith primers specific for the transgenes (one primer specific 
for the SV40 intron in each transgene, the other specific for the 5’end 
of each integrin cDNA). As an initial screen of transgene expression, 
total RNA was isolated from the skin, heart, and liver of control and 
transgene-positive animals; RT-PCR was then carried out as de- 
scribed previously (Carroll et al., 1993) with transgene-specific and 
actin primers. 
To determine transgene copy number, we isolated genomic DNA 
from mouse tail snips and digested the DNA with restriction enzymes 
excising a large piece of each respective transgenic DNA. Digests 
were electrophoresed on 1% agarose gels, blotted onto nylon, and 
probed with a human involucrin DNA probe consisting of a 1.4 kb 
Sac1 fragment of the involucrin upstream region. Copy numbers were 
determined as previously described (Carroll et al., 1993), except that 
an IL-2 receptor probe (single copy gene; probe provided by M. Owen, 
Imperial Cancer Research Fund) was used to control for loading. 
Histology, Immunofluorescence, and In Situ Hybridization 
Tissues from transgenic and transgene-negative mice matched ac- 
cording to sex and body site were used for all tissue studies. For 
histolpgical analysis, tissues were fixed overnight in formol-saline, 
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embedded in paraffin, sectioned, and stained with hematoxylin and 
eosin. Chloroacetate esterase was used as a histochemical marker for 
neutrophils. TUNEL was performed essentially as described by Gav- 
rieli et al. (1992) on paraffin sections of normal and transgenic mice. 
In situ hybridization was performed essentially as described by 
Stoler et al. (1988), using paraformaldhyde-fixed, paraffin-embedded 
sections of mouse skin. The probes were all ?S-labeled human integrin 
specific riboprobes (from pGEM4 integrin cDNA plasmids), approxi- 
mately 500 bp in length. Sense probes were always used as controls. 
For immunofluorescence studies, mouse tissues were placed in 
OCT and snap frozen in an isopentane bath cooled with liquid nitrogen. 
Frozen sections of 8 urn thickness were cut on a cryostat. Sections 
were stained essentially as described previously (Hertle et al., 1992) 
with the following modifications. After a brief fixation in acetone or 
paraformaldehyde, sections were blocked in 5% FCS, incubated with 
primary antibody, washed in PBS, and incubated with the appropriate 
fluorescent-conjugated secondary antibody. As a control, sections 
were stained with secondary antibodies alone. 
For double-labeled immunofluorescence, cultured keratinocytes 
were fixed in 3.7% formaldehyde, 0.4% Triton X-100 in PBS for 10 
min at room temperature. They were incubated simultaneously with 
both primary antibodies (P5D2, an anti-human 8, antibody, and an 
anti-mouse involucrin antibody) for 1 hr at room temperature, washed 
in PBS, and incubated with a mixture of secondary antibodies (FITC- 
conjugated sheep anti-rabbit IgG and Texas red-conjugated goat anti- 
mouse IgG; 1 hr at room temperature), washed in PBS, and mounted 
in Gelvatol (Monsanto Corporation). 
Primary antibodies used in this study were as follows: Hal/29 and 
Ha2/11 (hamster anti-mouse a$, and hamster anti-mouse f3,, respec- 
tively: provided by D. Mendrick, Harvard Medical School; Mendrick 
and Kelly, 1993); 161 (rabbit anti-as; provided by E. Marcantonio, Co- 
lumbia University; Hynes et al., 1988); HAS-6 (mouse anti-human 02; 
see Jones and Watt, 1993); GoH3 (rat anti-as; Serotec; see Jones 
and Watt, 1993); CD29 (mouse anti-human B1; CLB Company); P5D2 
(mouse anti-human pI; American Type Culture Collection; see Hertle 
et al., 1995); 8A2 (mouse anti-human 8, activating antibody; gift of N. 
Kovach, University of Washington; see Hotchin et al., 1993); rabbit 
anti-mouse involucrin (gift of M. Simon, State University of New York 
at Stony Brook or purchased from BAbCo; Djian et al., 1993); AFl09 
and AF66 (rabbit anti-mouse Kl and K6, respectively; provided by S. 
Yuspa, National Institutes of Health; Roop et al., 1984); rat anti-CD3, 
antiCD4, antiCD8, and anti-CD54 (ICAM-1) (all from PharMingen); 
rabbit anti-Ki-67 (Novacastra). 
Isolation and Culture of Mouse Keratinocytes 
Mouse epidermal keratinocytes were isolated as described by Morris 
(1994). In brief, adult mice were killed by CO, asphyxiation, shaved, 
and sequentially dipped in povidone iodine solution (0.75% stock solu- 
tion, diluted I:10 in distilled water), distilled water, and 70% ethanol. 
The skin was removed, rinsed thoroughly in PBS containing 100 UI 
ml penicillin, 100 uglml streptomycin, and 100 U/ml nystatin, and 
placed in 0.25% trypsin for 2-3 hr at 32OC. The epidermis wasscraped 
from the dermis and stirred in calcium-free FAD (one part Ham’s F12, 
three parts DMEM, 1.8 x 10e4 M adenine, 200 U/ml penicillin, 200 pg/ 
ml streptomycin) containing 10% FCS for 20 min at room temperature. 
Cells were filtered through a 70 pm Teflon mesh, centrifuged, and 
resuspended in culture medium. Cells were then seeded onto 
vitrogen-fibronectin-coated dishes (Morris, 1994). 
Two types of culture medium were used: SPRD-111, which is a 
fully defined high calcium medium (Morris, 1994) or calcium-freeMEM 
containing 8% Chelex-treated FCS. The MEM was supplemented as 
described by Miller et al. (1987), except that 100 U/ml penicillin and 
100 Kg/ml streptomycin were used instead of gentamycin. The calcium 
concentration in the complete MEM formulation was approximately 
0.05 mM. 
Adhesion Assays 
For assays of the total number of cells adhering to collagen and fibro- 
nectin, bacteriological plastic 96-well microtiter plates were coated 
overnight at 4°C with human type IV collagen (Sigma) or fibronectin 
(BioProducts Laboratory) diluted to the required concentration in PBS. 
Plates were then rinsed with PBS, blocked in 0.5 mglml heat-denatured 
BSA (Sigma) for 1 hr at 37”C, and rinsed again with PBS before addi- 
tion of cells. Keratinocytesgrown in SPRD-111 medium were detached 
from the dishes by trypsin-EDTA treatment, washed in calcium-free 
FAD containing 10% FCS to inactivate the trypsin, and resuspended 
in SPRD-111 medium. Cells were plated at a concentration of IO4 
cells per well and incubated at 37OC for 2 hr. Nonadherent cells were 
washed off, and adhesion was quantitated by measuring LDH activity 
(CytoTox 96 nonradioactive cytotoxicity assay; Promega). Each test 
was performed in triplicate wells, and SEMs were calculated. The 
number of cells that attached to uncoated BSA-blocked wells was 
subtracted from the number of adherent cells in each experiment. 
To assess the number of adherent involucrin-positive cells, we 
plated keratinocytes on 8-well chambered slides (Nunc) coated with 
type IV collagen or fibronectin, as described above, at a concentration 
of 2 x 10d cells per well in the presence or absence of a human 
8,specific blocking (250 uglml P5D2) or activating (10 ug/ml 8A2) 
antibody. After washing away nonadherent cells, we fixed the re- 
maining adherent cells in 3.7% formaldehyde in PBS (10 min at room 
temperature) permeabilized in absolute methanol (5 min on ice) and 
immunostained with rabbit anti-mouse involucrin. Each test was per- 
formed in duplicate wells, and the proportion of attached cells that were 
involucrin positive was determined from photographs of microscopical 
fields selected at random. Typically, 200-800 cells were scored per 
sample. Data were subjected to x2 analysis. 
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